Hrt Financial LP Amarin Corp Plcuk Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Hrt Financial LP holds 25,900 shares of AMRN stock, worth $11,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,900

Previous 14,842 74.5%

Holding current value

$11,396

Previous $10,000 60.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.57 - $0.8 $6,303 - $8,846	11,058 Added 74.5%	25,900 $16,000
Q2 2024 Aug 12, 2024	SELL	$0.63 - $1.07 $261 - $444	-415 Reduced 2.72%	14,842 $10,000
Q1 2024 May 13, 2024	BUY	$0.82 - $1.35 $12,510 - $20,596	15,257 New	15,257 $13,000
Q1 2023 May 12, 2023	BUY	$1.19 - $2.19 $48,447 - $89,159	40,712 New	40,712 $61,000
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $1,667 - $5,446	-1,476 Reduced 3.86%	36,746 $54,000
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $108,932 - $142,568	38,222 New	38,222 $125,000
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $48,710 - $77,876	-15,034 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $50,684 - $75,125	-12,864 Reduced 46.11%	15,034 $76,000
Q2 2021 Aug 16, 2021	BUY	$4.26 - $6.5 $118,845 - $181,337	27,898 New	27,898 $122,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $269,223 - $465,227	-56,323 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $165,900 - $892,956	41,475 Added 279.33%	56,323 $225,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $707,092 - $1.22 Million	-50,724 Reduced 77.36%	14,848 $318,000
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $910,795 - $1.52 Million	65,572 New	65,572 $994,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account